Literature DB >> 15512790

Improved experimental procedures for achieving efficient germ line transmission of nonobese diabetic (NOD)-derived embryonic stem cells.

Satoko Arai1, Christina Minjares, Seiho Nagafuchi, Toru Miyazaki.   

Abstract

The manipulation of a specific gene in NOD mice, the best animal model for insulin-dependent diabetes mellitus (IDDM), must allow for the precise characterization of the functional involvement of its encoded molecule in the pathogenesis of the disease. Although this has been attempted by the cross-breeding of NOD mice with many gene knockout mice originally created on the 129 or C57BL/6 strain background, the interpretation of the resulting phenotype(s) has often been confusing due to the possibility of a known or unknown disease susceptibility locus (e.g., Idd locus) cosegregating with the targeted gene from the diabetes-resistant strain. Therefore, it is important to generate mutant mice on a pure NOD background by using NOD-derived embryonic stem (ES) cells. By using the NOD ES cell line established by Nagafuchi and colleagues in 1999 (FEBS Lett., 455, 101-104), the authors reexamined various conditions in the context of cell culture, DNA transfection, and blastocyst injection, and achieved a markedly improved transmission efficiency of these NOD ES cells into the mouse germ line. These modifications will enable gene targeting on a "pure" NOD background with high efficiency, and contribute to clarifying the physiological roles of a variety of genes in the disease course of IDDM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512790      PMCID: PMC2478631          DOI: 10.1080/15438600490486877

Source DB:  PubMed          Journal:  Exp Diabesity Res        ISSN: 1543-8600


  7 in total

Review 1.  Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

Authors:  John P Driver; Yi-Guang Chen; Clayton E Mathews
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 2.  Genetic analysis of type 1 diabetes: embryonic stem cells as new tools to unlock biological mechanisms in type 1 diabetes.

Authors:  Nick Holmes; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  "Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells.

Authors:  Jing Chen; Peter C Reifsnyder; Felix Scheuplein; William H Schott; Maria Mileikovsky; Sharon Soodeen-Karamath; Andras Nagy; Michael H Dosch; James Ellis; Friedrich Koch-Nolte; Edward H Leiter
Journal:  Mamm Genome       Date:  2005-10-29       Impact factor: 2.957

Review 4.  Plasticity of human menstrual blood stem cells derived from the endometrium.

Authors:  Jian Lin; Dennis Xiang; Jin-long Zhang; Julie Allickson; Charlie Xiang
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

5.  NOD x 129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice.

Authors:  Edward H Leiter; Peter C Reifsnyder; Racheal Wallace; Renhua Li; Benjamin King; Gary C Churchill
Journal:  Diabetes       Date:  2009-03-31       Impact factor: 9.461

6.  Validated germline-competent embryonic stem cell lines from nonobese diabetic mice.

Authors:  Jennifer Nichols; Kenneth Jones; Jenny M Phillips; Stephen A Newland; Mila Roode; William Mansfield; Austin Smith; Anne Cooke
Journal:  Nat Med       Date:  2009-06-02       Impact factor: 53.440

7.  Optimization of protocols for derivation of mouse embryonic stem cell lines from refractory strains, including the non obese diabetic mouse.

Authors:  Timothy J Davies; Paul J Fairchild
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.